Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.
了解更多
When to Launch an LDT: Key Factors to Consider
According to an MLO article, cost is just one element in a complex decision
A new article in Medical Laboratory Observer offers a practical look at the factors to consider when deciding whether to design a new laboratory-developed test or choose a send-out reference lab test or an in vitro diagnostic.
Continue Reading >
xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.
Watch more videos >
May 7
Luminex Corporation Reports First Quarter 2018 Financial Results
April 16
Luminex Corporation First Quarter Earnings Release Scheduled for May 7, 2018
March 8
Luminex Corporation to Present at the Barclays Global Healthcare Conference
February 12
Luminex Corporation Reports Fourth Quarter and Full-Year 2017 Financial Results
February 6
Luminex Corporation To Present At LEERINK Partners 7th Annual Global Healthcare Conference
ESPID
May 28 – June 2
Malmo, Sweden
APHL Annual Meeting
June 2-4
Pasadena, CA
PSI Annual Meeting
June 3-6
Beurs Van Berlage, Amsterdam
ASM Microbe 2018
June 7-11
Atlanta, GA
Drug Discovery Summit
June 7-8
Berlin, Germany
